Medtronic (NYSE:MDT) today announced that it has initiated the Define AFib app-based research study.— a first of its kind for the company. The medtech giant will conduct the atrial fibrillation (AFib) study remotely using data collected from its Linq family of insertable cardiac monitors (ICM) on its Medtronic Discovery App. The goal is to address questions […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
FDA clears Front Line Medical arterial occlusion system
Front Line Medical Technologies today announced that its COBRA-OS bleeding control device won FDA 510(k) clearance. The COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) is a 4 French REBOA (resuscitative endovascular balloon occlusion of the aorta) device that provides full occlusion, intermittent occlusion or partial occlusion depending on a patient’s needs. Get the full story […]
CardioFocus names new CFO
CardioFocus today said it appointed Stephan Ogilvie as chief financial officer. Prior to joining the Marlborough, Mass.-based company, Ogilvie served as managing director of healthcare investment banking at B Riley Securities. He has also served as VP of corporate development at Nuvasive and has held numerous leadership roles at ThinkEquity Partners, Lazard Capital Markets and Medtronic. […]
FDA grants PMA to Abiomed’s next-generation Impella RP
Abiomed (NSDQ:ABMD) announced today that the FDA granted premarket approval (PMA) to its Impella RP with SmartAssist. Danvers, Mass.–based Abiomed received PMA for the Impella RP right heart pump with SmartAssist as a safe and effective treatment for acute right heart failure for up to 14 days, according to a news release. The company touts […]
DTW Weekly Podcast – Digging Deeper into Cleerly Health’s $43 million round
In this week’s DeviceTalks Weekly Podcast, we talk with Dr. James Min, the founder and CEO of Cleerly Health, a potentially disruptive diagnostics company that raised $43 million last week. Min explains how Cleerly Health formed from his work at Weill Cornell Medicine. But, more importantly, for entrepreneurs and executives, he walks listeners through the […]
Medtronic warns on Linq II insertable cardiac monitoring systems
Medtronic (NYSE:MDT) recently issued a warning letter regarding an issue with its Linq II insertable cardiac monitors (ICMs). Fridley, Minn.-based Medtronic’s warning informs users that Linq II ICMs that undergo a partial electrical reset appear to be programmed “ON,” but are no longer able to detect and report Brady, Pause and PVC events to clinicians. […]
RapidAI launches workflow platform for pulmonary embolism
RapidAI announced today that it launched its mobile and web-based app to aid in the treatment of pulmonary embolism (PE). San Mateo, Calif.-based RapidAI made available the Rapid Workflow for PE, which it designed to align hospital teams on the treatment of patients suspected of having a pulmonary embolism, according to a news release. Rapid […]
Boston Scientific pulls trigger on Farapulse acquisition
Boston Scientific (NYSE:BSX) announced today that it exercised its option to acquire the remaining shares of Farapulse. Marlborough, Mass.-based Boston Scientific first announced its intent to acquire Farapulse in September 2020, when it signed an investment agreement with an option to acquire the pulsed-field ablation (PFA) technology developer. Boston Scientific has been an investor in […]
CardioFocus wins Japan regulatory approval for HeartLight X3 system
CardioFocus today said its HeartLight X3 catheter ablation technology received approval from the Japanese Ministry of Health, Labor and Welfare. Marlborough, Mass.-based CardioFocus designed the catheter ablation technology for controlled and consistent pulmonary vein isolation to treat atrial fibrillation (AFib). Get the full story on our sister site, Medical Tubing + Extrusion.
Cleerly launches digital heart attack prevention software following $43M Series B
Cleerly today said it has launched its digital care software for heart attack prevention following a $43 million Series B funding round. New York–based Cleerly’s digital care technology is a non-invasive coronary computed tomography angiography that performs coronary artery phenotyping through artificial intelligence. According to the company, it uses millions of annotated lab images to […]
Medtronic wins expanded FDA approval for cryoablation catheters
Medtronic (NYSE:MDT) announced today that it received FDA expanded approval for its Arctic Front family of cardiac cryoablation catheters. Fridley, Minn.–based Medtronic’s Arctic Front family of catheters treat recurrent symptomatic paroxysmal atrial fibrillation (AFib) as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy. Get the full story at our sister site, […]